Raloxifene

QualityTools

Comparative Effectiveness of Therapies for Reducing the Risk of Primary Breast Cancer: Guidance for Shared Decision Making 10/12/11

This educational program for clinicians provides information about the Agency for Healthcare Research and Quality’s (AHRQ’s) systematic review of the comparative effectiveness and safety of tamoxifen, raloxifene, and tibolone for reducing the...

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.

Back to top Go back to top